These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Protease inhibitors and diabetes: a growing problem. Colvin R Common Factor; 1997 Nov; (No 11):8. PubMed ID: 11364847 [TBL] [Abstract][Full Text] [Related]
11. Glucose tolerance in HIV-1 treated patients who switched from boosted-protease inhibitors to etravirine. Carbone A; Bigoloni A; Galli L; Spagnuolo V; Gianotti N; Lazzarin A; Castagna A AIDS; 2013 Oct; 27(16):2661-3. PubMed ID: 24096632 [No Abstract] [Full Text] [Related]
12. Drug interactions in HIV-positive patients initiated on protease inhibitor therapy. Preston SL; Postelnick M; Purdy BD; Petrolati J; Aasi H; Stein DS AIDS; 1998 Jan; 12(2):228-30. PubMed ID: 9468380 [No Abstract] [Full Text] [Related]
17. Health advisory: high blood sugar and diabetes seen in protease inhibitor users. Crit Path AIDS Proj; 1998; (No 33):31-2. PubMed ID: 11366367 [TBL] [Abstract][Full Text] [Related]
19. Diuretics and diarrhea: a dangerous combination: a teachable moment. Liu P; Nikels M; Combs B JAMA Intern Med; 2014 Feb; 174(2):182. PubMed ID: 24275796 [No Abstract] [Full Text] [Related]
20. [Protease inhibitors--new preparations for treatment of HIV infections]. Lundgren JD Ugeskr Laeger; 1998 Jan; 160(4):451-6. PubMed ID: 9463265 [No Abstract] [Full Text] [Related] [Next] [New Search]